Cargando…

Impact of early catheter removal during treatment of invasive candidiasis: analysis from two phase 3 micafungin trials

Detalles Bibliográficos
Autores principales:	Nucci, M, Betts, R, Dupont, B, Wu, C, Buell, D, Kovanda, L, Lortholary, O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084079/ http://dx.doi.org/10.1186/cc7357

Ejemplares similares

Pharmacokinetics of micafungin in adult patients with invasive candidiasis and candidaemia
por: Kuse, ER, et al.
Publicado: (2008)

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
por: Wiederhold, Nathan P, et al.
Publicado: (2009)

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis
por: Benjamin, Daniel K., et al.
Publicado: (2018)

Micafungin for the treatment of pediatric invasive fungal infections
por: Arrieta, A, et al.
Publicado: (2009)

Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
por: Dupont, Bertrand F, et al.
Publicado: (2009)

Epidemiological cohort study of systemic antifungal therapy for suspected or confirmed invasive candidiasis in the ICU: the Amarcand2 study
por: Constantin, J, et al.
Publicado: (2015)

Pooled analysis of safety for micafungin
por: Cornely, OA, et al.
Publicado: (2008)

Exposure–Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials
por: Kovanda, Laura L., et al.
Publicado: (2018)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature
por: Glöckner, A
Publicado: (2011)

Pharmacokinetics of micafungin in patients with severe burn injuries
por: Sasaki, J, et al.
Publicado: (2012)

Pharmacokinetics of micafungin in patients with severe burn injuries
por: Sasaki, J, et al.
Publicado: (2011)

Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study
por: van der Geest, Patrick J., et al.
Publicado: (2016)

Demographic and outcome differences in ICU patients with proven invasive candidiasis, possible invasive candidiasis and probable candida colonization: analysis of the EPIC II study population
por: Kett, D, et al.
Publicado: (2011)

Plasma and Cerebrospinal Fluid Concentrations of Micafungin Administered at High Doses in Critically Ill Infants with Systemic Candidiasis: A Pooled Analysis of Two Studies
por: De Rose, Domenico Umberto, et al.
Publicado: (2023)

Toll like receptor 1 polymorphisms and susceptibility to invasive candidiasis
por: Plantinga, T, et al.
Publicado: (2009)

Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients
por: Ruhnke, M, et al.
Publicado: (2011)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs - review of the literature
por: Wilke, MH
Publicado: (2011)

Characterizing Safety and Clinical Outcomes Associated with High-Dose Micafungin Utilization in Patients with Proven Invasive Candidiasis
por: Grant, Victoria C., et al.
Publicado: (2022)

Micafungin concentrations 100 mg daily in plasma and burn eschars in patients with severe burn injuries
por: Agrifoglio, A, et al.
Publicado: (2015)

Differences between intraabdominal candidiasis in regular wards versus intensive care unit
por: Lagunes, L, et al.
Publicado: (2015)

Antifungal De-Escalation Is Safe in Critically Ill Patients Treated For Suspected Or Documented Invasive Candidiasis. Data From The Amarcand2 Study
por: Bailly, S, et al.
Publicado: (2015)

Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study
por: Viscoli, Claudio, et al.
Publicado: (2014)

Accidental catheter removal in the intensive care unit: a prospective observational study
por: Myatra, S, et al.
Publicado: (2005)

A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis
por: Kohno, S., et al.
Publicado: (2012)

Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis
por: Ashizawa, Nobuyuki, et al.
Publicado: (2019)

1167. Got Micafungin? The Incidence of Fungemia in Patients with Septic Shock
por: Piche, Mackenzie, et al.
Publicado: (2020)

P017: Reduction of catheter associated urinary tract infections following removal of unnecessary urinary catheters in a tertiary care hospital in Saudi Arabia
por: Abdulmutalib, DA, et al.
Publicado: (2013)

Removal of drug delivered via a central venous catheter by a dual-lumen haemodiafiltration catheter inserted at the same site: a quantitative flow model
por: Kam, R, et al.
Publicado: (2011)

Caspase-1 and ASC but not NLRP3 mediate antifungal defense in candidiasis sepsis
por: Veerdonk, F van de, et al.
Publicado: (2009)

Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin
por: Shirazi, Fazal, et al.
Publicado: (2015)

61. Evaluation of the Impact of a Micafungin Time-Out Protocol for Hospitalized Patients
por: Williams, Kelsey N, et al.
Publicado: (2020)

Removal of an implanted central venous catheter from neutropenic patients admitted to the ICU due to sepsis from any source
por: Martin, B Civantos, et al.
Publicado: (2015)

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis()
por: Denning, David W., et al.
Publicado: (2006)

Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure
por: Veerdonk, FL van de, et al.
Publicado: (2009)

Immunoglobulins concentration in HIV-infected patients' with viral hepatitis, candidiasis and herpes simplex viral infection
por: Sargsyants, Narina, et al.
Publicado: (2012)

Autoimmunity and cystatin SA 1 deficiency behind chronic mucocutaneous candidiasis in autoimmune polyendocrine syndrome
por: Lindh, Emma, et al.
Publicado: (2012)

Successful treatment of pulmonary candidiasis and aspergillosis in patient with refractory Hodgkin lymphoma using micafungin – case study and brief literature review
por: Barańska, Marta, et al.
Publicado: (2017)

Arterial catheter-related infection according to the catheter site
por: Lorente, L, et al.
Publicado: (2009)

Catheter-related infection of arterial catheters in critical care
por: Lorente, L, et al.
Publicado: (2004)

594. Micafungin Prophylaxis in Acute Myeloid Leukemia Adult Patients Undergoing Induction Chemotherapy
por: Ross, Justine Abella, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qq8bbpgdc4fq3b6g85k8dtrvgc